Dr. Lal PathLabs Limited disclosed the incorporation of a step-down subsidiary company in Tashkent, Uzbekistan under Regulation 30 of SEBI Listing Regulations.
Key Details of the Subsidiary
- Name of Entity: Dr Lal PathLabs Indomed LLC
- Date of Incorporation: August 19, 2026
- Location: Tashkent, Uzbekistan
- Industry: Diagnostic Services
- Business Activity: The entity will be engaged in providing diagnostics services.
- Financial History: Not applicable as it is a newly incorporated company with no historical turnover.
Ownership Structure
- Dr Lal PathLabs FZCO, Dubai (Wholly Owned Subsidiary) has agreed to subscribe to 70% of the share capital of Dr Lal PathLabs Indomed LLC.
- The subscription will be at face value using cash consideration.
Purpose and Impact
The primary object is to strengthen the Group's presence in Tashkent, Uzbekistan. The acquisition does not constitute a related party transaction, and no promoters/promoter group/group companies have any interest in the acquired entity.
Regulatory Approvals and Timeline
- No governmental or regulatory approvals are required for this incorporation.
- The acquisition timeline is not applicable as the company has already been incorporated.
Financial Impact
The financial impact of the subscription is not quantified in the disclosure, as the investment will be made at face value.